Cited by 436Alzheimer's disease research and treatmentsMicroRNA in disease regulationNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

MicroRNA regulation of Alzheimer's Amyloid precursor protein expression

Open access

Hébert, Sébastien S., Horré, Katrien, Nicolaï, Laura, Bergmans, Bruno, Papadopoulou, Aikaterini S., Delacourte, André, De Strooper, Bart·2009·Neurobiology of Disease

DOI 10.1016/j.nbd.2008.11.009

Open this paper in CoChat — free account

Abstract

Gene dosage effects of Amyloid precursor protein (APP) can cause familial AD. Recent evidence suggest that microRNA (miRNA) pathways, implicated in gene transcriptional control, could be involved in the development of sporadic Alzheimer's disease (AD). We therefore investigated whether miRNAs could participate in the regulation of APP gene expression. We show that miRNAs belonging to the miR-20a family (that is, miR-20a, miR-17-5p and miR-106b) could regulate APP expression in vitro and at the endogenous level in neuronal cell lines. A tight correlation between these miRNAs and APP was found during brain development and in differentiating neurons. We thus identify miRNAs as novel endogenous regulators of APP expression, suggesting that variations in miRNA expression could contribute to changes in APP expression in the brain during development and disease. This possibility is further corroborated by the observation that a statistically significant decrease in miR-106b expression was found in sporadic AD patients.

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2008.11.009

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Untitled work
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 1×
“The Aβ peptides accumulating in the brain of AD patients result from proteolytic cleavage of APP by β- and γ-secretases (De Strooper et al., 1998; Vassar et al., 1999; Haass, 2004).”
Background
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S., Großhans, H., Shingara, J., Byrom, M., JARVIS, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,699
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando, E., Mu, D., Goodson, S. G., Powers, S., Cordon‐Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,642
The impact of microRNAs on protein output
Baek, D., Villén, J., Shin, C., Camargo, F. D., Gygi, S. P., & Bartel, D. P. (2008) · Nature · doi:10.1038/nature07242 · Cited by 3,592
Widespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818

Show all 39 references

Sorted by citations

Repression of α-synuclein expression and toxicity by microRNA-7
Junn, E., Lee, K.-W., Jeong, B. S., Chan, T. W., Im, J.-Y., & Mouradian, M. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906277106 · Cited by 634
Identifying miRNAs, targets and functions
Liu, B., Li, J., & Cairns, M. J. (2014) · Briefings in Bioinformatics · doi:10.1093/bib/bbs075 · Cited by 563
The Role of MicroRNAs in Human Diseases.
Ardekani, A. M., & Naeini, M. M. (2010) · Europe PMC (PubMed Central) · Cited by 554
A blood based 12-miRNA signature of Alzheimer disease patients
Leidinger, P., Backes, C., Deutscher, S., Schmitt, K., Mueller, S. C., Frese, K., Haas, J., Ruprecht, K., Paul, F., Stähler, C., et al. (2013) · Genome biology · doi:10.1186/gb-2013-14-7-r78 · Cited by 509
Alterations of the microRNA network cause neurodegenerative disease
Hébert, S. S., & De Strooper, B. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.12.003 · Cited by 452
Self-citation
Exosomes: Vehicles for the Transfer of Toxic Proteins Associated with Neurodegenerative Diseases?
Bellingham, S. A., Guo, B. B., Coleman, B. M., & Hill, A. F. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00124 · Cited by 412
The epigenetics of aging and neurodegeneration
Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.002 · Cited by 381
The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases
Finnerty, J. R., Wang, W.-X., Hébert, S. S., Wilfred, B. R., Mao, G., & Nelson, P. T. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.07.051 · Cited by 371
Self-citation
Systematic Review of miRNA as Biomarkers in Alzheimer’s Disease
Swarbrick, S., Wragg, N. M., Ghosh, S. K., & Stolzing, A. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1500-y · Cited by 369
Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration
Hébert, S. S., Papadopoulou, A. S., Smith, P. Y., Galas, M., Planel, E., Silahtaroglu, A., Sergeant, N., Buée, L., & Strooper, B. D. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq311 · Cited by 334
Self-citation
S-Glutathionylation: From Molecular Mechanisms to Health Outcomes
Xiong, Y., Uys, J. D., Tew, K. D., & Townsend, D. M. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3540 · Cited by 314
The role of microRNAs in endometriosis and associated reproductive conditions
Ohlsson Teague, E. M. C., Print, C. G., & Hull, M. L. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp034 · Cited by 309
MicroRNAs in Alzheimer’s Disease
Wang, M., Qin, L., & Tang, B. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00153 · Cited by 311
Aberrant microRNA expression in the brains of neurodegenerative diseases: miR‐29a decreased in Alzheimer disease brains targets neurone navigator 3
Shioya, M., Obayashi, S., Tabunoki, H., Arima, K., Saito, Y., Ishida, T., & Satoh, J. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01076.x · Cited by 245
Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach
Singh, S., & Singh, T. G. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200207120949 · Cited by 307
De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease
Wong, H.-K. A., Veremeyko, T., Patel, N., Lemere, C. A., Walsh, D. M., Esau, C., Vanderburg, C., & Krichevsky, A. M. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt164 · Cited by 271
MiR-26b, upregulated in Alzheimer’s disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons
Absalon, S., Kochanek, D. M., Raghavan, V., & Krichevsky, A. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1327-13.2013 · Cited by 302
miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation
Wang, X., Liu, P., Zhu, H., Xu, Y., Ma, C., Dai, X., Huang, L., Liu, Y., Zhang, L., & Qin, C. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.08.006 · Cited by 271
Analytical aspects of microRNA in diagnostics: A review
Planell-Saguer, M. D., & Rodicio, M. C. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.05.025 · Cited by 266
MicroRNA-101 Regulates Amyloid Precursor Protein Expression in Hippocampal Neurons
Vilardo, E., Barbato, C., Ciotti, M., Cogoni, C., & Ruberti, F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.112664 · Cited by 241
miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo
Smith, P. Y., Hernandez-Rapp, J., Jolivette, F., Lecours, C., Bisht, K., Goupil, C., Dorval, V., Parsi, S., Morin, F., Planel, E., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv377 · Cited by 220
Self-citation
MicroRNAs as Effectors of Brain Function with Roles in Ischemia and Injury, Neuroprotection, and Neurodegeneration
Saugstad, J. A. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.101 · Cited by 228
MiR-107 is Reduced in Alzheimer's Disease Brain Neocortex: Validation Study
Nelson, P. T., & Wang, W.-X. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091603 · Cited by 222
Circulating miR-125b as a biomarker of Alzheimer's disease
Tan, L., Yu, J., Liu, Q.-Y., Tan, M., Zhang, W., Hu, N., Wang, Y.-L., Sun, L., Jiang, T., & Tan, L. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.10.002 · Cited by 227
MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders
Maes, O. C., Chertkow, H. M., Wang, E., & Schipper, H. M. (2009) · Current Genomics · doi:10.2174/138920209788185252 · Cited by 223
The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease
Fang, M., Wang, J., Zhang, X., Geng, Y., Hu, Z., Rudd, J. A., Ling, S., Chen, W., & Han, S. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.11.032 · Cited by 221
Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases
Wu, Y.-Y., & Kuo, H.-C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00636-z · Cited by 213
Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-β
Schonrock, N., Ke, Y. D., Humphreys, D., Staufenbiel, M., Ittner, L. M., Preiss, T., & Götz, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011070 · Cited by 211
In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs: APP splicing is regulated by microRNAs
Smith, P., Al Hashimi, A., Girard, J., Delay, C., & Hébert, S. S. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07097.x · Cited by 182
Self-citation
MicroRNA-101 downregulates Alzheimer’s amyloid-β precursor protein levels in human cell cultures and is differentially expressed
Long, J. M., & Lahiri, D. K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.053 · Cited by 211
Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
Grasso, M., Piscopo, P., Confaloni, A., & Denti, M. (2014) · Molecules · doi:10.3390/molecules19056891 · Cited by 208
The microRNA cluster miR-106b 25 regulates adult neural stem/progenitor cell proliferation and neuronal differentiation
Brett, J. O., Renault, V. M., Rafalski, V. A., Webb, A. E., & Brunet, A. (2011) · Aging · doi:10.18632/aging.100285 · Cited by 207
A Novel MicroRNA-124/PTPN1 Signal Pathway Mediates Synaptic and Memory Deficits in Alzheimer’s Disease
Wang, X., Liu, D., Huang, H., Wang, Z., Hou, T., Yang, X., Pang, P., Wei, N., Zhou, Y., Dupras, M.-J., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.07.023 · Cited by 206
Self-citation
Changes in Brain MicroRNAs Contribute to Cholinergic Stress Reactions
Meerson, A., Cacheaux, L. P., Goosens, K. A., Sapolsky, R. M., Soreq, H., & Kaufer, D. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9252-1 · Cited by 209
MicroRNA-153 Physiologically Inhibits Expression of Amyloid-β Precursor Protein in Cultured Human Fetal Brain Cells and Is Dysregulated in a Subset of Alzheimer Disease Patients
Long, J. M., Ray, B., & Lahiri, D. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.366336 · Cited by 198
Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases
Konovalova, J., Gerasymchuk, D., Parkkinen, I., Chmielarz, P., & Domanskyi, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236055 · Cited by 204
MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice
Liu, W., Chang, L., Zhu, J.-X., Shu, P., Yin, B., Gong, Y., Qiang, B., Yuan, J., & Peng, X. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.034 · Cited by 193
MicroRNAs in age‐related diseases
Dimmeler, S., & Nicotera, P. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201986 · Cited by 188
MicroRNA-339-5p Down-regulates Protein Expression of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 (BACE1) in Human Primary Brain Cultures and Is Reduced in Brain Tissue Specimens of Alzheimer Disease Subjects
Long, J. M., Ray, B., & Lahiri, D. K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.518241 · Cited by 187
Neuronal dark matter: the emerging role of microRNAs in neurodegeneration
Goodall, E. F., Heath, P. R., Bandmann, O., Kirby, J., & Shaw, P. J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00178 · Cited by 187
MicroRNAs in Alzheimer's disease
Delay, C., Mandemakers, W., & Hébert, S. S. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.01.003 · Cited by 185
Self-citation
Identification and quantitative analyses of microRNAs located in the distal axons of sympathetic neurons
Natera-Naranjo, O., Aschrafi, A., Gioio, A. E., & Kaplan, B. B. (2010) · RNA · doi:10.1261/rna.1833310 · Cited by 180
MicroRNAs: Master Regulators of Ethanol Abuse and Toxicity?
Miranda, R. C., Pietrzykowski, A. Z., Tang, Y., Sathyan, P., Mayfield, D., Keshavarzian, A., Sampson, W., & Hereld, D. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01126.x · Cited by 179
hnRNP C promotes APP translation by competing with FMRP for APP mRNA recruitment to P bodies
Lee, E. K., Kim, H. H., Kuwano, Y., Abdelmohsen, K., Srikantan, S., Subaran, S. S., Gleichmann, M., Mughal, M. R., Martindale, J. L., Yang, X., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1815 · Cited by 174
miR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression
Kim, J., Yoon, H., Ramírez, C. M., Lee, S.-M., Hoe, H.-S., Fernández-Hernando, C., & Kim, J. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.010 · Cited by 173
Stress-induced changes in miRNA biogenesis and functioning
Olejniczak, M., Kotowska‐Zimmer, A., & Krzyżosiak, W. J. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2591-0 · Cited by 184
Non-coding RNAs in Alzheimer's Disease
Tan, L., Yu, J.-T., Hu, N., & Tan, L. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8359-5 · Cited by 174
MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways
El Fatimy, R., Li, S., Chen, Z., Mushannen, T., Gongala, S., Wei, Z., Balu, D. T., Rabinovsky, R., Cantlon, A., Elkhal, A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1880-5 · Cited by 161
MicroRNAs in Neurodegenerative Diseases
(2017) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2017.04.002 · Cited by 168
Exosomes: Potential Disease Biomarkers and New Therapeutic Targets
Mosquera-Heredia, M. I., Morales, L. C., Vidal, O. M., Barceló, E., Silvera-Redondo, C. A., Velez, J. I., & Garavito, P. (2021) · Biomedicines · doi:10.3390/biomedicines9081061 · Cited by 173
The roles of amyloid precursor protein (APP) in neurogenesis
Zhou, Z., Chan, C. H.-S., Ma, Q., Xu, X., Xiao, Z., & Tan, E. (2011) · Cell Adhesion & Migration · doi:10.4161/cam.5.4.16986 · Cited by 180
miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia – an exploratory study
Sørensen, S. S., Nygaard, A., & Christensen, T. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0053-5 · Cited by 167
Target Gene Repression Mediated by miRNAs miR-181c and miR-9 Both of Which Are Down-regulated by Amyloid-β
Schönrock, N., Humphreys, D. T., Preiß, T., & Götz, J. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9587-2 · Cited by 163
Resveratrol as a Natural Autophagy Regulator for Prevention and Treatment of Alzheimer’s Disease
Kou, X., & Chen, N. (2017) · Nutrients · doi:10.3390/nu9090927 · Cited by 165
MicroRNAs, Long Noncoding RNAs, and Their Functions in Human Disease
Xue, M., Zhuo, Y., & Shan, B. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7046-9_1 · Cited by 154
MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy
Smith, P. Y., Delay, C., Girard, J., Papon, M.-A., Planel, E., Sergeant, N., Buée, L., & Hébert, S. S. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr330 · Cited by 136
Self-citation
Angiogenesis-regulating microRNAs and Ischemic Stroke
Yin, K., Hamblin, M., & Chen, Y. (2015) · Current Vascular Pharmacology · doi:10.2174/15701611113119990016 · Cited by 153
The role of microRNAs in self-renewal and differentiation of mesenchymal stem cells
Guo, L., Zhao, R. C., & Wu, Y. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.01.011 · Cited by 149
Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer’s disease: An integrative review
Millan, M. J. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.004 · Cited by 151
Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis
Kandimalla, R. J. L., & Reddy, P. H. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.018 · Cited by 148
Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders
Delgado‐Morales, R., Agís‐Balboa, R. C., Esteller, M., & Berdasco, M. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0365-z · Cited by 146
microRNA-132/212 deficiency enhances Aβ production and senile plaque deposition in Alzheimer’s disease triple transgenic mice
Hernandez-Rapp, J., Rainone, S., Goupil, C., Dorval, V., Smith, P. Y., Saint‐Pierre, M., Vallée, M., Planel, E., Droit, A., Calon, F., et al. (2016) · Scientific Reports · doi:10.1038/srep30953 · Cited by 144
Self-citation
A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease
Reddy, P. H., Tonk, S., Kumar, S., Vijayan, M., Kandimalla, R., Kuruva, C. S., & Reddy, A. P. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.067 · Cited by 143
Epigenetic mechanisms in Alzheimer's disease: Implications for pathogenesis and therapy
Wang, J., Yu, J., Tan, M., Jiang, T., & Tan, L. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.05.003 · Cited by 140
Imperfect centered miRNA binding sites are common and can mediate repression of target mRNAs
Martin, H. C., Wani, S., Steptoe, A. L., Krishnan, K., Nones, K., Nourbakhsh, E., Vlassov, A. V., Grimmond, S. M., & Cloonan, N. (2014) · Genome biology · doi:10.1186/gb-2014-15-3-r51 · Cited by 134
The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Walgrave, H., Zhou, L., Strooper, B. D., & Salta, E. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00496-7 · Cited by 137
Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis
McKiernan, R. C., Jimenez-Mateos, E. M., Bray, I., Engel, T., Brennan, G. P., Sano, T., Michalak, Z., Moran, C., Delanty, N., Farrell, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035921 · Cited by 115
Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function
Delay, C., Calon, F., Mathews, P. M., & Hébert, S. S. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-70 · Cited by 133
Self-citation
miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor
Wang, H., Liu, J., Zong, Y., Xu, Y., Deng, W., Zhu, H., Liu, Y. M., Ma, C., Huang, L. J., Zhang, L., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.023 · Cited by 130
microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain
Kim, J., Yoon, H., Horie, T., Burchett, J. M., Restivo, J. L., Rotllan, N., Ramírez, C. M., Verghese, P. B., Ihara, M., Hoe, H.-S., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2053-15.2015 · Cited by 128
“Recently, microRNAs (miRNAs) have emerged as a new class of therapeutic targets for various diseases, including neurodegenerative disorders (Nelson and Keller, 2007; Hébert et al., 2009).”
Background
Epigenomics of Alzheimer's disease
Bennett, D. A., Yu, L., Yang, J., Srivastava, G. P., Aubin, C., & Jager, P. L. D. (2014) · Translational research · doi:10.1016/j.trsl.2014.05.006 · Cited by 126
Extracellular Vesicle as a Source of Alzheimer’s Biomarkers: Opportunities and Challenges
Lee, S., Mankhong, S., & Kang, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071728 · Cited by 129
Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases
Tan, L., Yu, J.-T., & Tan, L. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8803-9 · Cited by 126
MicroRNAs and deregulated gene expression networks in neurodegeneration
Sonntag, K. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.106 · Cited by 130
MicroRNA pharmacogenomics: Post-transcriptional regulation of drug response
Rukov, J. L., & Shomron, N. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.04.003 · Cited by 124
A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer’s disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls
Hébert, S. S., Wang, W.-X., Zhu, Q., & Nelson, P. T. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122350 · Cited by 125
Self-citation
Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes
Soreq, L., Salomonis, N., Bronstein, M., Greenberg, D., Israel, Z. H., Bergman, H., & Soreq, H. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00010 · Cited by 124
microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases
Basak, I., Patil, K. S., Alves, G., Larsen, J. P., & Møller, S. G. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2093-x · Cited by 107
Circulating Nucleic Acids in Plasma and Serum
Gahan, P. B., & Swaminathan, R. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.050 · Cited by 121
Epigenetically regulated microRNAs in Alzheimer's disease
van den Hove, D., Kompotis, K., Lardenoije, R., Kenis, G., Mill, J. S., Steinbusch, H. W. M., Lesch, K., Fitzsimons, C. P., Strooper, B. D., & Rutten, B. P. F. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.082 · Cited by 120
Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease
Siedlecki‐Wullich, D., Català-Solsona, J., Fábregas, C., Hernández, I., Clarimón, J., Lleó, A., Boada, M., Saura, C. A., Rodrı́guez-Álvarez, J., & Miñano-Molina, A. J. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0501-4 · Cited by 117
The detection of microRNA associated with Alzheimer's disease in biological fluids using next-generation sequencing technologies
Cheng, L., Quek, C. Y. J., Sun, X., Bellingham, S. A., & Hill, A. F. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00150 · Cited by 113
MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy
Li, Y.-B., Fu, Q., Guo, M., Du, Y., Chen, Y., & Cheng, Y. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03075-8 · Cited by 128
The Regulation of microRNAs in Alzheimer's Disease
Kou, X., Chen, D., & Chen, N. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00288 · Cited by 112
MicroRNA-144 Is Regulated by Activator Protein-1 (AP-1) and Decreases Expression of Alzheimer Disease-related A Disintegrin and Metalloprotease 10 (ADAM10)
Cheng, C., Li, W., Zhang, Z., Yoshimura, S., Hao, Q., Zhang, C., & Wang, Z. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.381392 · Cited by 115
RNA and Oxidative Stress in Alzheimer’s Disease: Focus on microRNAs
Nunomura, A., & Perry, G. L. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2638130 · Cited by 111
MicroRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2
Liang, C., Zhu, H., Xu, Y., Huang, L. J., Ma, C., Deng, W., Liu, Y. M., & Qin, C. (2011) · Brain Research · doi:10.1016/j.brainres.2011.10.051 · Cited by 111
MicroRNA in central nervous system trauma and degenerative disorders
Liu, N., & Xu, X. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00168.2010 · Cited by 114
MicroRNA expression in extracellular vesicles as a novel blood‐based biomarker for Alzheimer's disease
Kumar, A., Su, Y., Sharma, M., Singh, S., Kim, S., Peavey, J. J., Suerken, C. K., Lockhart, S. N., Whitlow, C. T., Craft, S., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13055 · Cited by 113
MicroRNA-195Protects Against Dementia Induced by Chronic Brain Hypoperfusion via Its Anti-Amyloidogenic Effect in Rats
Ai, J., Sun, L., Che, H., Zhang, R., Zhang, T.-Z., Wu, W.-C., Su, X., Chen, X., Yang, G., Li, K., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1997-12.2013 · Cited by 109
Amyloid Beta and MicroRNAs in Alzheimer’s Disease
Amakiri, N., Kubosumi, A., Tran, J., & Reddy, P. H. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00430 · Cited by 107
miRNA-31 Improves Cognition and Abolishes Amyloid-β Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer’s Disease
Barros-Viegas, A. T., Carmona, V., Ferreiro, E. B., Guedes, J. R., Cardoso, A. M., Cunha, P. S., de Almeida, L. P., Oliveira, C. R., Peça, J., Peça, J., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.01.010 · Cited by 111
microRNA involvement in developmental and functional aspects of the nervous system and in neurological diseases
Christensen, M., & Schratt, G. M. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.04.043 · Cited by 113
Converging miRNA functions in diverse brain disorders: A case for miR-124 and miR-126
Sonntag, K., Woo, T.-U. W., & Krichevsky, A. M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.035 · Cited by 107
Exosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy
Iranifar, E., Seresht, B. M., Momeni, F., Fadaei, E., Mehr, M. H., Ebrahimi, Z., Rahmati, M., Kharazinejad, E., & Mirzaei, H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27214 · Cited by 93
Brain‐Penetration and Neuron‐Targeting DNA Nanoflowers Co‐Delivering miR‐124 and Rutin for Synergistic Therapy of Alzheimer's Disease
Ouyang, Q., Liu, K., Zhu, Q., Deng, H., Le, Y., Ouyang, W., Yan, X., Zhou, W., & Tong, J. (2022) · Small · doi:10.1002/smll.202107534 · Cited by 94
Epigenetic Mechanisms in Stroke and Epilepsy
Hwang, J.-Y., Aromolaran, K. A., & Zukin, R. S. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.134 · Cited by 105
microRNAs and Neurodegenerative Diseases
Qiu, L., Tan, E., & Zeng, L. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22671-2_6 · Cited by 102
Dysregulation of protein synthesis and disease
Quesne, J. P. C. L., Spriggs, K. A., Bushell, M., & Willis, A. E. (2009) · The Journal of Pathology · doi:10.1002/path.2627 · Cited by 102
miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells
Fan, X., Liu, Y., Jiang, J., Ma, Z., Wu, H., Liu, T., Liu, M., Li, X., & Tang, H. (2010) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmq026 · Cited by 95

Authors: Hébert, S. S., Horré, K., Nicolaï, L., Bergmans, B., Papadopoulou, A. S., Delacourte, A., & De Strooper, B.
Affiliations: KU Leuven (BE)
Inserm (FR)
ORCID: Hébert, Sébastien S.
Horré, Katrien
Bergmans, Bruno
Papadopoulou, Aikaterini S.
Venue: Neurobiology of Disease
Publisher: Elsevier BV
Published: 2009-03
Volume: 33
Issue: 3
Pages: 422-428
ISSN: 0969-9961 (ISSN-L)
DOI: 10.1016/j.nbd.2008.11.009
OpenAlex: W2072484559
Cited by: 436
References: 39
Citations by year: 2026: 7 · 2025: 27 · 2024: 19 · 2023: 24 · 2022: 22 · 2021: 29 · 2020: 19 · 2019: 24 · 2018: 16 · 2017: 21 · 2016: 26 · 2015: 26 · 2014: 27 · 2013: 39 · 2012: 25
FWCI: 19.22
Type: journal article
Language: en
Open access: green
doaj.org
Licence: cc-by-sa
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: Neurobiology of Disease (publishedVersion)
PubMed (publishedVersion)
Ghent University Academic Bibliography (Ghent University) (submittedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
UCL Discovery (University College London) (submittedVersion)
Lirias (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: microRNA, amyloid precursor protein, Alzheimer's disease, miR-20a, miR-17-5p, miR-106b, gene expression regulation, neuronal differentiation, brain development, sporadic Alzheimer's disease, familial Alzheimer's disease
MeSH terms: Actins, Animals, Brain, Cell Line, Cells, Cultured, Densitometry, Gene Expression Regulation, Humans, Neurons, Receptors, Cell Surface, RNA, Messenger, Transfection, Blotting, Northern, Blotting, Western, Amyloid beta-Protein Precursor, Reverse Transcriptase Polymerase Chain Reaction, MicroRNAs, Mice, Neurogenesis, Protease Nexins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

MicroRNA regulation of Alzheimer's Amyloid precursor protein expression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks